These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 3034847)
1. Protective effect of forphenicinol, a low molecular weight immunomodifier, against infection with Pseudomonas aeruginosa in mice and its mechanisms. Naito K; Arakawa H; Watanabe Y; Okura A; Ishizuka M; Takeuchi T; Umezawa H J Antibiot (Tokyo); 1987 Apr; 40(4):547-54. PubMed ID: 3034847 [TBL] [Abstract][Full Text] [Related]
2. Antitumor effect of forphenicinol, a low molecular weight immunomodifier, on murine transplantable tumors and microbial infections. Ishizuka M; Masuda T; Kanbayashi N; Watanabe Y; Matsuzaki M; Sawazaki Y; Ohkura A; Takeuchi T; Umezawa H J Antibiot (Tokyo); 1982 Aug; 35(8):1049-54. PubMed ID: 7142006 [TBL] [Abstract][Full Text] [Related]
3. Immunopotentiation with forphenicinol: increased resistance to Pseudomonas septicaemia in mice. Ishibashi T; Harada Y; Takamoto M; Shinoda A J Antibiot (Tokyo); 1985 Mar; 38(3):430-2. PubMed ID: 4008335 [No Abstract] [Full Text] [Related]
4. Effect of forphenicinol, a low molecular weight immunomodifier, on the growth of and the immune responses to murine lymphoma EL4. Okura A; Naito K; Iizuka H; Ishizuka M; Takeuchi T; Umezawa H J Biol Response Mod; 1987 Feb; 6(1):35-43. PubMed ID: 3559627 [TBL] [Abstract][Full Text] [Related]
5. Antitumor effect of forphenicinol, a low molecular weight immunomodifier, in combination with surgery on Meth A fibrosarcoma, Lewis lung carcinoma, and adenocarcinoma 755. Okura A; Sawazaki Y; Naito K; Ishizuka M; Takeuchi T; Umezawa H J Antibiot (Tokyo); 1986 Apr; 39(4):564-8. PubMed ID: 3710915 [TBL] [Abstract][Full Text] [Related]
6. Protective effect of a traditional Chinese medicine, xiao-chai-hu-tang (Japanese name: shosaiko-to), on Pseudomonas aeruginosa infection in mice. Kawakita T; Yamada A; Mitsuyama M; Kumazawa Y; Nomoto K Immunopharmacol Immunotoxicol; 1987; 9(4):523-40. PubMed ID: 3437105 [TBL] [Abstract][Full Text] [Related]
7. Effect of forphenicinol on gamma-interferon production in mice sensitized with BCG. Okura A; Nakadaira M; Naito K; Ishizuka M; Takeuchi T; Umezawa H J Antibiot (Tokyo); 1986 Apr; 39(4):569-74. PubMed ID: 3011721 [TBL] [Abstract][Full Text] [Related]
8. [Clinical trial of a new immunomodulator, forphenicinol, against chronic respiratory infections]. Matsumoto K; Nagatake T; Rikitomi N; Uzuka Y; Harada T; Taguchi M; Suzuki H Kansenshogaku Zasshi; 1985 Jul; 59(7):766-76. PubMed ID: 3932556 [No Abstract] [Full Text] [Related]
9. Studies on effects of forphenicinol on immune responses. Ishizuka M; Ishizeki S; Masuda T; Momose A; Aoyagi T; Takeuchi T; Umezawa H J Antibiot (Tokyo); 1982 Aug; 35(8):1042-8. PubMed ID: 7142005 [TBL] [Abstract][Full Text] [Related]
10. Effect of forphenicinol on the production of Ia-positive macrophages in mice with or without L1210 leukemia and on the growth of L1210 in immunized mice. Okura A; Arakawa H; Yoshinari T; Naito K; Ishizuka M; Takeuchi T; Umezawa H J Antibiot (Tokyo); 1986 Apr; 39(4):575-80. PubMed ID: 3458691 [TBL] [Abstract][Full Text] [Related]
11. Efficacy comparison of adjuvants in PcrV vaccine against Pseudomonas aeruginosa pneumonia. Hamaoka S; Naito Y; Katoh H; Shimizu M; Kinoshita M; Akiyama K; Kainuma A; Moriyama K; Ishii KJ; Sawa T Microbiol Immunol; 2017 Feb; 61(2):64-74. PubMed ID: 28370521 [TBL] [Abstract][Full Text] [Related]
12. Protective effect of granulocyte colony-stimulating factor (G-CSF) in a granulocytopenic mouse model of Pseudomonas aeruginosa lung infection through enhanced phagocytosis and killing by alveolar macrophages through priming tumour necrosis factor-alpha (TNF-alpha) production. Shirai R; Kadota J; Tomono K; Ogawa K; Iida K; Kawakami K; Kohno S Clin Exp Immunol; 1997 Jul; 109(1):73-9. PubMed ID: 9218827 [TBL] [Abstract][Full Text] [Related]
13. Immunization with outer membrane proteins (OprF and OprI) and flagellin BÂ protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa. Hassan R; El-Naggar W; Abd El-Aziz AM; Shaaban M; Kenawy HI; Ali YM J Microbiol Immunol Infect; 2018 Jun; 51(3):312-320. PubMed ID: 28291719 [TBL] [Abstract][Full Text] [Related]
14. Stimulatory effect of forphenicinol on normal human bone marrow granulocyte-macrophage progenitor cells mediated by T-lymphocytes. Ohhara N; Okamura S; Otsuka T; Harada M; Niho Y Biomed Pharmacother; 1987; 41(8):425-8. PubMed ID: 3502533 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of human gamma-globulin preparation in experimental pseudomonas aeruginosa infections in mice and its mode of action. Kamimura T Arzneimittelforschung; 1984; 34(11):1528-34. PubMed ID: 6084512 [TBL] [Abstract][Full Text] [Related]
16. Interaction of elastase from Pseudomonas aeruginosa with polymorphonuclear leukocytes and serum. Pajdak E; Pituch-Noworolska A; Stankiewicz D Arch Immunol Ther Exp (Warsz); 1985; 33(4):499-505. PubMed ID: 3936453 [TBL] [Abstract][Full Text] [Related]
17. Limited role for interleukin-18 in the host protection response to pulmonary infection with Pseudomonas aeruginosa in mice. Nakasone C; Kawakami K; Hoshino T; Kawase Y; Yokota K; Yoshino K; Takeda K; Akira S; Saito A Infect Immun; 2004 Oct; 72(10):6176-80. PubMed ID: 15385528 [TBL] [Abstract][Full Text] [Related]
18. Macrophage inflammatory protein-2 is a mediator of polymorphonuclear neutrophil influx in ocular bacterial infection. Kernacki KA; Barrett RP; Hobden JA; Hazlett LD J Immunol; 2000 Jan; 164(2):1037-45. PubMed ID: 10623854 [TBL] [Abstract][Full Text] [Related]
19. Contribution of humoral and cellular factors to the resistance to experimental infection by Pseudomonas aeruginosa in mice. I. Interaction between immunoglobulins, heat-labile serum factors, and phagocytic cells in the killing of bacteria. Bjornson AB; Michael JG Infect Immun; 1971 Oct; 4(4):462-7. PubMed ID: 5005303 [TBL] [Abstract][Full Text] [Related]
20. Vitamin D3 enhances bactericidal activity of macrophage against Pseudomonas aeruginosa. Nouari W; Ysmail-Dahlouk L; Aribi M Int Immunopharmacol; 2016 Jan; 30():94-101. PubMed ID: 26655879 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]